etrials Worldwide to Report Second Quarter 2008 Financial Results

Business Wire, August 1, 2008

MORRISVILLE, N.C. -- etrials([R]) Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical software and services that optimize clinical trial management by turning data into intelligence and shortening the pathway to an actionable study endpoint will release financial results for the three months ended June 30, 2008 on Tuesday, August 12, 2008, after the markets close. etrials will also host a conference call at 4:30 p.m. Eastern that day. During the call, Robert Brill, Chairman of the Board, Chuck Piccirillo, interim chief executive officer and Jay Trepanier, interim chief financial officer will discuss the company's growth strategy and plans to enhance shareholder value, quarterly performance and financial results.

To participate in the live call by telephone, please dial 800-480-2207, or, for international callers, please dial 706-643-7866 and reference ID number 57135185. Those interested in listening to the conference call live via the Internet may do so by visiting the company's web site at www.etrials.com. Please go to the web site 15 minutes prior to the scheduled start to register, download and install any necessary audio software. A web cast audio replay and a telephone audio replay will also be available for two weeks by dialing 800-642-1687 from the US or 706-645-9291 for international callers and entering conference ID number 57135185 when prompted.

About etrials[R]

etrials Worldwide, Inc. (Nasdaq: ETWC) a leading provider of eClinical software and services to pharmaceutical, biotechnology, medical device, and contract research organizations offers adaptive, Web-based tools that work together to coordinate data capture, logistics, patient interaction and trial management - turning data into intelligence and shortening the pathway to an actionable study endpoint. With global operations, etrials is the only top-tier solutions provider to offer electronic data capture (EDC), interactive voice and Web response (IVR/IWR), electronic patient diaries (eDiary) as part of a flexible and integrated software-as-a-service (SaaS) platform or as individual solutions to capture high quality data from multiple pivot points to enable real-time access for perfectly informed decision-making. As an experienced leader, etrials has facilitated over 900 trials involving more than 400,000 patients in 60 countries; and has participated in 33 studies used for new drug applications. To learn more visit us at www.etrials.com. etwcf

etrials is registered trademark in the United States of etrials Worldwide, Inc. Other marks belong to their respective owners and are used with permission.